NL-OMON37766已完成不适用
Parallel-group, single and multiple dose interventional study investigating the tolerability and pharmacokinetic properties of Lu AF35700 in healthy young men - 14198A
undbeck0 个研究点目标入组 29 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 29
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male
排除标准
- •Clinical significant abnormalities at medical research
研究者
相似试验
已完成
不适用
Randomized, single dose, parallel group, bioequivalence study, comparing trastuzumab (Synthon BV, the Netherlands) to Herceptin® (Hoffmann-La Roche, Switzerland) infusion in healthy male volunteers following a placebo-controlled dose escalation period10006291Breast cancerNL-OMON35365Synthon BV118
进行中（未招募）
不适用
Bioequivalence study with clinical endpoint in the treatment of subjects with chronic open-angle glaucoma or ocular hypertension in both eyes.CTRI/2022/04/042203Amneal EU Limited
进行中（未招募）
不适用
ong-Term Extension Study of BIIB023 in Subjects with Lupus Nephritisupus NephritisMedDRA version: 18.1Level: PTClassification code 10025140Term: Lupus nephritisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2013-000594-69-HUBiogen Idec Research Limited220
进行中（未招募）
不适用
ong-Term Extension Study of BIIB023 in Subjects with Lupus Nephritisupus NephritisMedDRA version: 17.1Level: PTClassification code 10025140Term: Lupus nephritisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2013-000594-69-PLBiogen Idec Research Limited220
进行中（未招募）
不适用
ong-Term Extension Study of BIIB023 in Subjects with Lupus Nephritisupus NephritisMedDRA version: 17.0Level: PTClassification code 10025140Term: Lupus nephritisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2013-000594-69-PTBiogen Idec Research Limited220